Cancer Clinical Trial
Official title:
A Pilot Randomized Factorial Trial to Promote Physical Activity and Healthy Eating Among Young Adult Cancer Survivors
Verified date | June 2024 |
Source | UNC Lineberger Comprehensive Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this pilot randomized factorial trial is to test the feasibility, acceptability, and effects of a theory-based mobile physical activity and nutrition intervention designed specifically for young adult cancer survivors to increase physical activity and diet quality.
Status | Active, not recruiting |
Enrollment | 70 |
Est. completion date | November 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 39 Years |
Eligibility | Inclusion Criteria: - Current age 18-39 years at the time of consent - Diagnosed with invasive cancer malignancy between the ages of 15-39 years - Diagnosed with invasive malignancy in the last 10 years of diagnosis, and with no evidence of progressive disease or second primary cancers - Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention), except may be receiving "maintenance" therapy to prevent recurrences - No pre-existing medical conditions(s) that preclude adherence to an unsupervised exercise program including cardiovascular disease, congestive heart failure, pulmonary conditions, renal disease, and severe orthopedic conditions - Not currently meeting guideline recommendations of 150 minutes/week moderate to vigorous physical activity (self-report) and guideline recommendations for fruit and vegetable consumption (self-report) - Have the ability to read, write and speak English - Have access to the Internet on at least a weekly basis - Possession and usage of an Internet e-mail address or willingness to sign up for a free email account (e.g., gmail) - Have smartphone with internet access and text messaging plan - Be willing to be randomized to any condition Exclusion Criteria: - History of heart attack or stroke within past 6 months - Untreated hypertension, hyperlipidemia, or diabetes, unless permission is provided by their health care provider - Health problems which preclude ability to walk for physical activity - Report a diagnosis of psychiatric diseases (schizophrenia, bipolar disorder, depression leading to hospitalization in the past year), drug or alcohol dependency - Report a past diagnosis of or treatment for a DSM-IV-TR eating disorder (anorexia nervosa or bulimia nervosa) - Plans for major surgery (e.g., breast reconstruction) during the study time frame - Current participation in another physical activity or weight control program - Currently using prescription weight loss medications - Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months - Currently exercising > 150 minutes/week of moderate-to-vigorous intensity physical activity - Currently consuming > 5 servings of fruits and vegetables/day. |
Country | Name | City | State |
---|---|---|---|
United States | Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
UNC Lineberger Comprehensive Cancer Center | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accrual rate | Number of participants who agreed to participate divided by the number of months of recruitment. | End of study enrollment period, approximately 6 months after enrollment initiation. | |
Primary | Participation rate | Percentage of eligible participants who agreed to participate. | End of study enrollment period, approximately 6 months after enrollment initiation. | |
Primary | Retention rate at 3 months | Number of intervention participants who completed 3-month measures divided by the number who consented to participate. | End of data collection period, approximately 12 months after enrollment initiation | |
Secondary | Acceptability of the intervention. | Ratings of program acceptability and satisfaction with the intervention, as measured by acceptability and satisfaction questionnaire. | 3 months | |
Secondary | Adherence to physical activity monitoring. | Number of days physical activity tracked, as measured by Fitbit. | Through study completion, 3 months. | |
Secondary | Adherence to diet self-monitoring | Number of days of complete dietary tracking. | Through study completion, 3 months. | |
Secondary | Moderate-to-vigorous physical activity (objective) | Change in levels of physical activity, as measured by Fitbit, from baseline to 3 months. Participants will wear a Fitbit on their wrist during a 7 day period. | Baseline, 6 weeks, 3 months. | |
Secondary | Self-reported physical activity | Moderate-to-vigorous physical activity will be defined as the change in self-reported weekly minutes of moderate-to-vigorous physical activity as measured by the Paffenbarger Activity Questionnaire from baseline to 12 weeks. The minimum is 0, no maximum. Higher numbers represent higher minutes of weekly moderate-to-vigorous physical activity. | Baseline, 6 weeks, 3 months. | |
Secondary | Dietary intake: Healthy Eating Index (HEI) | Dietary intake will be defined as the change in HEI score as measured by the NCI's Automated Self-Administered 24-hour (ASA 24-hour) dietary recalls from baseline to 3 months.The HEI consists of 13 component scores, including: total fruit, whole fruit, total protein foods, total vegetables, greens and beans, whole grains, dairy, seafood and plant proteins, fatty acids, sodium, refined grains, added sugars, and saturated fats. The summation of the 13 component scores ranges from 0 to 100, with higher scores indicating closer compliance with the Dietary Guidelines for Americans. | Baseline, 6 weeks, 3 months | |
Secondary | Weight | Absolute weight change from baseline to 3 months. Weight will be objectively measured on a scale in the participant's home. | Baseline, 6 weeks, 3 months | |
Secondary | Fried physical frailty phenotype: FRAIL Index | The FRAIL Questionnaire includes five components that assess: 1) self-reported fatigue (PROMIS Fatigue Short form), 2) weight loss, 3) comorbidities (11 items from UNC Health Registry Comorbidity Assessment), 4) difficulty with ambulation (1 item from PROMIS Physical Function Short Form), and 5) ability to overcome resistance (1 item from PROMIS Physical Function)). The number of positive responses for these components is summed to create the FRAIL index (range 0-5) and characterized as 0-1: robust, 2: prefrail, and 3+: frail. Changes in individual components and overall frailty scores from baseline to 3 months will be assessed. | Baseline, 6 weeks, 3 months | |
Secondary | Health-related Quality of Life: AYA PROMIS PRO Core Battery | Changes in health-related quality of life from baseline to 3 months as measured using the Adolescent and Young Adult (AYA)PROMIS PRO Core Battery. These measures assess relevant HRQoL domains for AYA cancer survivors that are most likely to be impacted during and after cancer treatment. The AYA PRO Core battery includes the following PROMIS short forms: depression, anxiety, fatigue, physical function, pain interference, emotional support, cognitive function, pain intensity. Each question has five responses ranging in value from 1 to 5, which are summed to find the total raw score. Total raw scores are translated to a T-score, standardized with a population mean of 50 and a standard deviation of 10. A higher PROMIS T-score represents more of the concept being measured. | Baseline, 6 weeks, 3 months | |
Secondary | Competence for Exercise and Nutrition | Changes in perceived competence from baseline to 3 months as measured using the Perceived Competence Scale includes 4 items that measure perceived competence for nutrition and 4 items for physical activity. Ratings are on a 7-point Likert scale with higher scores indicating greater perceived competence for the behavior. | Baseline, 6 weeks, 3 months | |
Secondary | Self-efficacy for Exercise and Nutrition | Changes in self-efficacy from baseline to 3 months as measured using the Nutrition and Physical Activity Self-Efficacy Scale, a 10-item scale that assesses an individual's confidence in their ability to eat healthy foods and exercise in the presence of barriers. Ratings are on a 4-point Likert scale with higher scores indicating greater self-efficacy for exercise and nutrition. | Baseline, 6 weeks, 3 months | |
Secondary | Self-regulation for Exercise and Nutrition | Changes in self-regulation from baseline to 3 months as measured using the Treatment Self-Regulation Questionnaire (TSRQ) will be used to assess autonomous and controlled motivation for making changes in diet (15 items) and physical activity (15 items). Ratings are on a 7-point Likert scale indicating agreement with statements regarding motivation for behavior change. | Baseline, 6 weeks, 3 months | |
Secondary | Autonomy Support and Relatedness | Changes in perceived autonomy support as measured using the Virtual Care Climate Questionnaire (VCCQ) a 15-item measure of perceived support for autonomy provided by the study team in a virtual care setting. Ratings are on a 7-point Likert scale with higher scores indicating a higher level of perceived autonomy support. | Baseline, 6 weeks, 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|